{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:09:16Z","timestamp":1792800556377,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:00:00Z","timestamp":1614384000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:00:00Z","timestamp":1614384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnologia","doi-asserted-by":"crossref","award":["S0008\u20132009\u20131-115250"],"award-info":[{"award-number":["S0008\u20132009\u20131-115250"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"crossref","award":["526"],"award-info":[{"award-number":["526"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"crossref"}]},{"name":"European Commission Horizon 2020 program","award":["H2020-MSCA-IF-2015-703787"],"award-info":[{"award-number":["H2020-MSCA-IF-2015-703787"]}],"id":[{"id":"https:\/\/ror.org\/00k4n6c32","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P30 DK40561"],"award-info":[{"award-number":["P30 DK40561"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Impaired fasting glucose (IFG) is a prevalent and potentially reversible intermediate stage leading to type 2 diabetes that increases risk for cardiometabolic complications. The identification of clinical and molecular factors associated with the reversal, or regression, from IFG to a normoglycemia state would enable more efficient cardiovascular risk reduction strategies. The aim of this study was to identify clinical and biological predictors of regression to normoglycemia in a non-European population characterized by high rates of type 2 diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a prospective, population-based study among 9637 Mexican individuals using clinical features and plasma metabolites. Among them, 491 subjects were classified as IFG, defined as fasting glucose between 100 and 125\u00a0mg\/dL at baseline. Regression to normoglycemia was defined by fasting glucose less than 100\u00a0mg\/dL in the follow-up visit. Plasma metabolites were profiled by Nuclear Magnetic Resonance. Multivariable cox regression models were used to examine the associations of clinical and metabolomic factors with regression to normoglycemia. We assessed the predictive capability of models that included clinical factors alone and models that included clinical factors and prioritized metabolites.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During a median follow-up period of 2.5\u00a0years, 22.6% of participants (n\u2009=\u2009111) regressed to normoglycemia, and 29.5% progressed to type 2 diabetes (n\u2009=\u2009145). The multivariate adjusted relative risk of regression to normoglycemia was 1.10 (95% confidence interval [CI] 1.25 to 1.32) per 10\u00a0years of age increase, 0.94 (95% CI 0.91\u20130.98) per 1 SD increase in BMI, and 0.91 (95% CI 0.88\u20130.95) per 1 SD increase in fasting glucose. A model including information from age, fasting glucose, and BMI showed a good prediction of regression to normoglycemia (AUC\u2009=\u20090.73 (95% CI 0.66\u20130.78). The improvement after adding information from prioritized metabolites (TG in large HDL, albumin, and citrate) was non-significant (AUC\u2009=\u20090.74 (95% CI 0.68\u20130.80), p value\u2009=\u20090.485).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In individuals with IFG, information from three clinical variables easily obtained in the clinical setting showed a good prediction of regression to normoglycemia beyond metabolomic features. Our findings can serve to inform and design future cardiovascular prevention strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-021-01246-1","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T10:04:07Z","timestamp":1614420247000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Clinical and metabolomic predictors of regression to normoglycemia in a population at intermediate cardiometabolic risk"],"prefix":"10.1186","volume":"20","author":[{"given":"Magdalena del Roc\u00edo","family":"Sevilla-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hortensia","family":"Moreno-Macias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalba","family":"Rojas-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donaj\u00ed Ver\u00f3nica","family":"G\u00f3mez-Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0247-902X","authenticated-orcid":false,"given":"Alisa K.","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,27]]},"reference":[{"key":"1246_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","volume":"138","author":"NH Cho","year":"2018","unstructured":"Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271\u201381.","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"1246_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/MCO.0000000000000307","volume":"19","author":"M Abdul-Ghani","year":"2016","unstructured":"Abdul-Ghani M, DeFronzo RA, Jayyousi A. Prediabetes and risk of diabetes and associated complications. Curr Opin Clin Nutr Metab Care. 2016;19(5):394\u20139.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"1246_CR3","doi-asserted-by":"publisher","first-page":"i5953","DOI":"10.1136\/bmj.i5953","volume":"355","author":"Y Huang","year":"2016","unstructured":"Huang Y, Cai X, Mai W, Li M, Hu Y. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ. 2016;355:i5953.","journal-title":"BMJ"},{"issue":"4","key":"1246_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJM199807233390404","volume":"339","author":"SM Haffner","year":"1998","unstructured":"Haffner SM, Lehto S, R\u00f6nnemaa T, Py\u00f6r\u00e4l\u00e4 K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339(4):229\u201334.","journal-title":"N Engl J Med"},{"issue":"9733","key":"1246_CR5","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","volume":"375","author":"N Sarwar","year":"2010","unstructured":"Sarwar N, Gao P, Seshasai SRK, Gobin R, Kaptoge S, Di Angelantonio E, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215\u201322.","journal-title":"Lancet"},{"issue":"9131","key":"1246_CR6","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","volume":"352","author":"R Turner","year":"1998","unstructured":"Turner R. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854\u201365.","journal-title":"Lancet"},{"issue":"5","key":"1246_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1056\/NEJMoa021778","volume":"348","author":"P G\u00e6de","year":"2003","unstructured":"G\u00e6de P, Vedel P, Larsen N, Jensen GVH, Parving H-H, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348(5):383\u201393. https:\/\/doi.org\/10.1056\/NEJMoa021778.","journal-title":"N Engl J Med"},{"issue":"9435","key":"1246_CR8","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","volume":"364","author":"HM Colhoun","year":"2004","unstructured":"Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HAW, Livingstone SJ, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the collaborative atorvastatin diabetes study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004;364(9435):685\u201396.","journal-title":"Lancet"},{"issue":"15","key":"1246_CR9","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1056\/NEJMoa0806359","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, Neil HAW, Matthews DR. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med. 2008;359(15):1565\u201376. https:\/\/doi.org\/10.1056\/NEJMoa0806359.","journal-title":"N Engl J Med"},{"issue":"9976","key":"1246_CR10","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","volume":"385","author":"J Fulcher","year":"2015","unstructured":"Fulcher J, O\u2019Connell R, Voysey M, Emberson J, Blackwell L, Mihaylova B, et al. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials. Lancet. 2015;385(9976):1397\u2013405.","journal-title":"Lancet"},{"key":"1246_CR11","first-page":"687","volume-title":"Diabetes care","author":"J Merino","year":"2017","unstructured":"Merino J, Leong A, Posner DC, Porneala B, Masana L, Dupuis J, et al. Genetically driven hyperglycemia increases risk of coronary artery disease separately from type 2 diabetes. In: Diabetes care. Arlington: American Diabetes Association Inc.; 2017. p. 687\u201393."},{"key":"1246_CR12","first-page":"1202","volume-title":"Diabetes care","author":"A Leong","year":"2019","unstructured":"Leong A, Chen J, Wheeler E, Hivert MF, Liu CT, Merino J, et al. Mendelian randomization analysis of hemoglobin A1c as a risk factor for coronary artery disease. In: Diabetes care. Arlington: American Diabetes Association Inc.; 2019. p. 1202\u20138."},{"issue":"9","key":"1246_CR13","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.2337\/dc09-0523","volume":"32","author":"L Perreault","year":"2009","unstructured":"Perreault L, Kahn SE, Christophi CA, Knowler WC, Hamman RF, Diabetes Prevention Program Research Group. Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program. Diabetes Care. 2009;32(9):1583\u20138.","journal-title":"Diabetes Care"},{"issue":"12","key":"1246_CR14","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.2337\/dc17-1116","volume":"40","author":"WH Herman","year":"2017","unstructured":"Herman WH, Pan Q, Edelstein SL, Mather KJ, Perreault L, Barrett-Connor E, et al. Impact of lifestyle and metformin interventions on the risk of progression to diabetes and regression to normal glucose regulation in overweight or obese people with impaired glucose regulation. Diabetes Care. 2017;40(12):1668\u201377.","journal-title":"Diabetes Care"},{"issue":"3","key":"1246_CR15","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/dme.13091","volume":"34","author":"DH Bodicoat","year":"2017","unstructured":"Bodicoat DH, Khunti K, Srinivasan BT, Mostafa S, Gray LJ, Davies MJ, et al. Incident Type 2 diabetes and the effect of early regression to normoglycaemia in a population with impaired glucose regulation. Diabet Med. 2017;34(3):396\u2013404. https:\/\/doi.org\/10.1111\/dme.13091.","journal-title":"Diabet Med"},{"issue":"11","key":"1246_CR16","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1111\/dme.13789","volume":"35","author":"Y-C Hwang","year":"2018","unstructured":"Hwang Y-C, Cho I-J, Jeong I-K, Ahn KJ, Chung HY. Factors associated with regression from prediabetes to normal glucose tolerance in a Korean general population: a community-based 10-year prospective cohort study. Diabet Med. 2018;35(11):1544\u201351. https:\/\/doi.org\/10.1111\/dme.13789.","journal-title":"Diabet Med"},{"issue":"9833","key":"1246_CR17","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1016\/S0140-6736(12)60525-X","volume":"379","author":"L Perreault","year":"2012","unstructured":"Perreault L, Pan Q, Mather KJ, Watson KE, Hamman RF, Kahn SE, et al. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the diabetes prevention program outcomes study. Lancet. 2012;379(9833):2243\u201351.","journal-title":"Lancet"},{"issue":"11","key":"1246_CR18","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.2337\/dc14-0407","volume":"37","author":"A Nanditha","year":"2014","unstructured":"Nanditha A, Ram J, Snehalatha C, Selvam S, Priscilla S, Shetty AS, et al. Early improvement predicts reduced risk of incident diabetes and improved cardiovascular risk in prediabetic Asian Indian men participating in a 2-year lifestyle intervention program. Diabetes Care. 2014;37(11):3009\u201315. https:\/\/doi.org\/10.2337\/dc14-0407.","journal-title":"Diabetes Care"},{"issue":"2","key":"1246_CR19","doi-asserted-by":"publisher","first-page":"e3097","DOI":"10.1002\/dmrr.3097","volume":"35","author":"C Aguayo-Mazzucato","year":"2019","unstructured":"Aguayo-Mazzucato C, Diaque P, Hernandez S, Rosas S, Kostic A, Caballero AE. Understanding the growing epidemic of type 2 diabetes in the Hispanic population living in the United States. Diabetes Metab Res Rev. 2019;35(2):e3097. https:\/\/doi.org\/10.1002\/dmrr.3097.","journal-title":"Diabetes Metab Res Rev"},{"issue":"7","key":"1246_CR20","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.metabol.2014.03.012","volume":"63","author":"CA Aguilar-Salinas","year":"2014","unstructured":"Aguilar-Salinas CA, Tusie-Luna T, Pajukanta P. Genetic and environmental determinants of the susceptibility of Amerindian derived populations for having hypertriglyceridemia. Metabolism. 2014;63(7):887\u201394. https:\/\/doi.org\/10.1016\/j.metabol.2014.03.012.","journal-title":"Metabolism"},{"issue":"10","key":"1246_CR21","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.3945\/jn.110.121533","volume":"140","author":"M Flores","year":"2010","unstructured":"Flores M, Macias N, Rivera M, Lozada A, Barquera S, Rivera-Dommarco J, et al. Dietary patterns in Mexican adults are associated with risk of being overweight or obese. J Nutr. 2010;140(10):1869\u201373.","journal-title":"J Nutr"},{"issue":"5","key":"1246_CR22","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2337\/dci18-0007","volume":"41","author":"W Yang","year":"2018","unstructured":"Yang W, Dall TM, Beronjia K, Lin J, Semilla AP, Chakrabarti R, et al. Economic costs of diabetes in the US in 2017. Diabetes Care. 2018;41(5):917\u201328.","journal-title":"Diabetes Care"},{"key":"1246_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature12828","volume":"506","author":"AL Williams","year":"2013","unstructured":"Consortium TST 2 D, Williams AL, Jacobs SBR, Moreno-Mac\u00edas H, Huerta-Chagoya A, Churchhouse C, et al. Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico. Nature. 2013;506:97. https:\/\/doi.org\/10.1038\/nature12828.","journal-title":"Nature"},{"issue":"1","key":"1246_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-019-0977-z","volume":"19","author":"N Katakami","year":"2020","unstructured":"Katakami N, Katakami N, Omori K, Taya N, Arakawa S, Takahara M, et al. Plasma metabolites associated with arterial stiffness in patients with type 2 diabetes. Cardiovasc Diabetol. 2020;19(1):1\u201318.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1246_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-019-0892-3","volume":"18","author":"GM Uddin","year":"2019","unstructured":"Uddin GM, Zhang L, Shah S, Fukushima A, Wagg CS, Gopal K, et al. Impaired branched chain amino acid oxidation contributes to cardiac insulin resistance in heart failure. Cardiovasc Diabetol. 2019;18(1):1\u201312.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"1246_CR26","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nm.2307","volume":"17","author":"TJ Wang","year":"2011","unstructured":"Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, et al. Metabolite profiles and the risk of developing diabetes. Nat Med. 2011;17(4):448\u201353.","journal-title":"Nat Med"},{"issue":"4","key":"1246_CR27","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1172\/JCI44442","volume":"121","author":"EP Rhee","year":"2011","unstructured":"Rhee EP, Cheng S, Larson MG, Walford GA, Lewis GD, McCabe E, et al. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest. 2011;121(4):1402\u201311.","journal-title":"J Clin Invest"},{"issue":"10","key":"1246_CR28","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1172\/JCI64801","volume":"123","author":"TJ Wang","year":"2013","unstructured":"Wang TJ, Ngo D, Psychogios N, Dejam A, Larson MG, Vasan RS, et al. 2-Aminoadipic acid is a biomarker for diabetes risk. J Clin Invest. 2013;123(10):4309\u201317.","journal-title":"J Clin Invest"},{"issue":"2","key":"1246_CR29","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2337\/db12-0495","volume":"62","author":"A Floegel","year":"2013","unstructured":"Floegel A, Stefan N, Yu Z, M\u00fchlenbruch K, Drogan D, Joost H-G, et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes. 2013;62(2):639\u201348. https:\/\/doi.org\/10.2337\/db12-0495.","journal-title":"Diabetes"},{"issue":"5","key":"1246_CR30","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.cmet.2012.01.024","volume":"15","author":"CB Newgard","year":"2012","unstructured":"Newgard CB. Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab. 2012;15(5):606\u201314.","journal-title":"Cell Metab"},{"key":"1246_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.metabol.2019.04.001","volume":"95","author":"Y Zeng","year":"2019","unstructured":"Zeng Y, Mtintsilana A, Goedecke JH, Micklesfield LK, Olsson T, Chorell E. Alterations in the metabolism of phospholipids, bile acids and branched-chain amino acids predicts development of type 2 diabetes in black South African women: a prospective cohort study. Metabolism. 2019;95:57\u201364.","journal-title":"Metabolism"},{"key":"1246_CR32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jchromb.2019.04.053","volume":"1120","author":"J Godzien","year":"2019","unstructured":"Godzien J, Kalaska B, Adamska-Patruno E, Siroka J, Ciborowski M, Kretowski A, et al. Oxidized glycerophosphatidylcholines in diabetes through non-targeted metabolomics: their annotation and biological meaning. J Chromatogr B Anal Technol Biomed Life Sci. 2019;1120:62\u201370.","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"issue":"3","key":"1246_CR33","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1373\/clinchem.2014.228965","volume":"61","author":"D Drogan","year":"2015","unstructured":"Drogan D, Dunn WB, Lin W, Buijsse B, Schulze MB, Langenberg C, et al. Untargeted metabolic profiling identifies altered serum metabolites of type 2 diabetes mellitus in a prospective, nested case control study. Clin Chem. 2015;61(3):487\u201397. https:\/\/doi.org\/10.1373\/clinchem.2014.228965.","journal-title":"Clin Chem"},{"issue":"9","key":"1246_CR34","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.2337\/dc14-0560","volume":"37","author":"GA Walford","year":"2014","unstructured":"Walford GA, Porneala BC, Dauriz M, Vassy JL, Cheng S, Rhee EP, et al. Metabolite traits and genetic risk provide complementary information for the prediction of future type 2 diabetes. Diabetes Care. 2014;37(9):2508\u201314. https:\/\/doi.org\/10.2337\/dc14-0560.","journal-title":"Diabetes Care"},{"issue":"6","key":"1246_CR35","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.2337\/dc19-2533","volume":"43","author":"J Vangipurapu","year":"2020","unstructured":"Vangipurapu J, Fernandes Silva L, Kuulasmaa T, Smith U, Laakso M. Microbiota-related metabolites and the risk of type 2 diabetes. Diabetes Care. 2020;43(6):1319\u201325.","journal-title":"Diabetes Care"},{"key":"1246_CR36","doi-asserted-by":"publisher","first-page":"101566","DOI":"10.1016\/j.isci","volume":"23","author":"SR Khan","year":"2020","unstructured":"Khan SR, Manialawy Y, Obersterescu A, Cox BJ, Gunderson EP, Wheeler MB. Diminished sphingolipid metabolism, a hallmark of future type 2 diabetes pathogenesis, is linked to pancreatic b cell dysfunction pancreatic beta-cell dysfunction glucose insulin release cell death prognostic biomarker for T2D T2D development. IScience. 2020;23:101566. https:\/\/doi.org\/10.1016\/j.isci.","journal-title":"IScience"},{"key":"1246_CR37","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.metabol.2019.06.011","volume":"98","author":"I Owei","year":"2019","unstructured":"Owei I, Umekwe N, Stentz F, Wan J, Dagogo-Jack S. Amino acid signature predictive of incident prediabetes: a case-control study nested within the longitudinal pathobiology of prediabetes in a biracial cohort. Metabolism. 2019;98:76\u201383.","journal-title":"Metabolism"},{"issue":"2","key":"1246_CR38","first-page":"68","volume":"2","author":"L Ruiz-Arregui","year":"2013","unstructured":"Ruiz-Arregui L, \u00c1vila-Funes JA, Amieva H, Borges-Y\u00e1\u00f1ez SA, Villa-Romero A, Aguilar-Navarro S, et al. The Coyoac\u00e1n cohort study: design, methodology, and participants\u2019 characteristics of a mexican study on nutritional and psychosocial markers of frailty. J Frailty Aging. 2013;2(2):68\u201376.","journal-title":"J Frailty Aging"},{"key":"1246_CR39","first-page":"S11","volume-title":"Diabetes care","author":"Association AD","year":"2010","unstructured":"Association AD. Standards of medical care in diabetes-2010. In: Diabetes care, vol. 33. Arlington: American Diabetes Association; 2010. p. S11."},{"issue":"7","key":"1246_CR40","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412\u20139.","journal-title":"Diabetologia"},{"issue":"5","key":"1246_CR41","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1530\/EJE-17-0883","volume":"178","author":"OY Bello-Chavolla","year":"2018","unstructured":"Bello-Chavolla OY, Almeda-Valdes P, Gomez-Velasco D, Viveros-Ruiz T, Cruz-Bautista I, Romo-Romo A, et al. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur J Endocrinol. 2018;178(5):533\u201344.","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"1246_CR42","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","volume":"35","author":"CL Craig","year":"2003","unstructured":"Craig CL, Marshall AL, Sj\u00f6str\u00f6m M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sport Exerc. 2003;35(8):1381\u201395.","journal-title":"Med Sci Sport Exerc"},{"issue":"5\u20136","key":"1246_CR43","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1242\/dmm.001180","volume":"2","author":"PL Huang","year":"2009","unstructured":"Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2(5\u20136):231\u20137.","journal-title":"Dis Model Mech"},{"key":"1246_CR44","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/msb.2010.93","volume":"6","author":"M Inouye","year":"2010","unstructured":"Inouye M, Kettunen J, Soininen P, Silander K, Ripatti S, Kumpula LS, et al. Metabonomic, transcriptomic, and genomic variation of a population cohort. Mol Syst Biol. 2010;6:441.","journal-title":"Mol Syst Biol"},{"issue":"3","key":"1246_CR45","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837\u201345.","journal-title":"Biometrics"},{"issue":"4","key":"1246_CR46","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/fampra\/cmw031","volume":"33","author":"VY Guo","year":"2016","unstructured":"Guo VY, Yu EY, Wong CK, Sit RW, Wang JH, Ho SY, et al. Validation of a nomogram for predicting regression from impaired fasting glucose to normoglycaemia to facilitate clinical decision making. Fam Pract. 2016;33(4):401\u20137. https:\/\/doi.org\/10.1093\/fampra\/cmw031.","journal-title":"Fam Pract"},{"issue":"12","key":"1246_CR47","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.2337\/diacare.26.12.3230","volume":"26","author":"J Lindstrom","year":"2003","unstructured":"Lindstrom J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, et al. The Finnish diabetes prevention study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care. 2003;26(12):3230\u20136.","journal-title":"Diabetes Care"},{"issue":"5","key":"1246_CR48","doi-asserted-by":"publisher","first-page":"e268","DOI":"10.1038\/nutd.2017.21","volume":"7","author":"G Duijzer","year":"2017","unstructured":"Duijzer G, Haveman-Nies A, Jansen SC, ter Beek J, van Bruggen R, Willink MGJ, et al. Effect and maintenance of the SLIMMER diabetes prevention lifestyle intervention in Dutch primary healthcare: a randomised controlled trial. Nutr Diabetes. 2017;7(5):e268.","journal-title":"Nutr Diabetes"},{"issue":"11","key":"1246_CR49","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.2337\/dc19-0100","volume":"42","author":"J Lu","year":"2019","unstructured":"Lu J, ManLam S, Wan Q, Shi L, Huo Y, Chen L, et al. High-coverage targeted lipidomics reveals novel serum lipid predictors and lipid pathway dysregulation antecedent to type 2 diabetes onset in normoglycemic Chinese adults. Diabetes Care. 2019;42(11):2117\u201326.","journal-title":"Diabetes Care"},{"key":"1246_CR50","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fphar.2015.00218","volume":"6","author":"A Kontush","year":"2015","unstructured":"Kontush A. HDL particle number and size as predictors of cardiovascular disease. Front Pharmacol. 2015;6:218.","journal-title":"Front Pharmacol"},{"issue":"4","key":"1246_CR51","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00439-012-1256-1","volume":"132","author":"AC Frazier-Wood","year":"2013","unstructured":"Frazier-Wood AC, Manichaikul A, Aslibekyan S, Borecki IB, Goff DC, Hopkins PN, et al. Genetic variants associated with VLDL, LDL and HDL particle size differ with race\/ethnicity. Hum Genet. 2013;132(4):405\u201313. https:\/\/doi.org\/10.1007\/s00439-012-1256-1.","journal-title":"Hum Genet"},{"key":"1246_CR52","volume-title":"Clinical methods: the history, physical, and laboratory examinations","author":"JT Busher","year":"1990","unstructured":"Busher JT. Serum albumin and globulin. In: Clinical methods: the history, physical, and laboratory examinations. Boston: Butterworths; 1990."},{"issue":"4","key":"1246_CR53","doi-asserted-by":"publisher","first-page":"e0176209","DOI":"10.1371\/journal.pone.0176209","volume":"12","author":"JE Jun","year":"2017","unstructured":"Jun JE, Lee SE, Lee YB, Jee JH, Bae JC, Jin SM, et al. Increase in serum albumin concentration is associated with prediabetes development and progression to overt diabetes independently of metabolic syndrome. PLoS ONE. 2017;12(4):e0176209.","journal-title":"PLoS ONE"},{"issue":"5","key":"1246_CR54","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00125-015-3520-0","volume":"58","author":"SK Kunutsor","year":"2015","unstructured":"Kunutsor SK, Khan H, Laukkanen JA. Serum albumin concentration and incident type 2 diabetes risk: new findings from a population-based cohort study. Diabetologia. 2015;58(5):961\u20137.","journal-title":"Diabetologia"},{"issue":"1","key":"1246_CR55","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/ije\/dyh299","volume":"34","author":"AG Barnett","year":"2004","unstructured":"Barnett AG. Regression to the mean: what it is and how to deal with it. Int J Epidemiol. 2004;34(1):215\u201320. https:\/\/doi.org\/10.1093\/ije\/dyh299.","journal-title":"Int J Epidemiol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-021-01246-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12933-021-01246-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-021-01246-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T10:05:29Z","timestamp":1614420329000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-021-01246-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,27]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1246"],"URL":"https:\/\/doi.org\/10.1186\/s12933-021-01246-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-109666\/v1","asserted-by":"object"}]},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,27]]},"assertion":[{"value":"13 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of the Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n. Written informed consent was obtained from each participant.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}